Products

Median LCS (internal name) / eyonis LCS (trade name) (1.0)
Median Technologies
Clinical Decision Support & Reference
eyonis LCS is an AI/ML-powered Software as a Medical Device (SaMD) for early cancer diagnosis, specifically designed for lung cancer screening. It assists clinicians in detecting and characterizing lung nodules on low-dose CT scans, aiming to improve diagnostic accuracy and reduce false positives and negatives.
eyonis® LCS
Median Technologies
Oncology AI

See all 2 products →

About Median Technologies

Median Technologies is a pioneering healthcare AI company that leverages artificial intelligence, computer vision, and signal processing technologies to develop innovative imaging tests and services. Their core mission is to transform medical images into actionable insights to improve the diagnosis, treatment, and monitoring of patients, particularly in oncology. They aim to address life-threatening unmet medical needs by enabling earlier diagnosis and more effective treatment strategies.

For physicians, Median Technologies offers two primary solutions: iCRO and eyonis®. The iCRO (Imaging Contract Research Organization) business unit provides advanced imaging services and AI-powered image analysis for oncology clinical trials. This helps biopharmaceutical companies accelerate drug development by validating drug candidates’ mechanisms of action, discovering predictive imaging biomarkers, selecting appropriate patients for clinical trials, and monitoring disease progression. The eyonis® platform is a suite of AI-powered Software as a Medical Device (SaMD) designed for early cancer diagnosis. Median Technologies is also developing additional SaMD within the eyonis® portfolio for incidental pulmonary nodules (IPN) and hepatocellular carcinoma (HCC).

Focus Areas

Medical image analysis oncology clinical trials AI-powered diagnostics early cancer detection precision medicine imaging biomarkers lung cancer screening liver cancer liver disease

Business Intelligence

TechnologyCloud-native, AI-powered imaging platform (eyonis®) leveraging proprietary artificial intelligence, computer vision, and signal processing technologies for imaging biomarker phenotyping and Software as Medical Devices (SaMD).

Products by Median Technologies

2 products in the directory

Median LCS (internal name) / eyonis LCS (trade name) (1.0)
Median Technologies
Clinical Decision Support & Reference
eyonis LCS is an AI/ML-powered Software as a Medical Device (SaMD) for early cancer diagnosis, specifically designed for lung cancer screening. It assists clinicians in detecting and characterizing lung nodules on low-dose CT scans, aiming to improve diagnostic accuracy and reduce false positives and negatives.
eyonis® LCS
Median Technologies
Oncology AI

Videos

News, demos, and interviews about Median Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Median Technologies →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Median Technologies develops AI-powered diagnostic solutions, notably their iBiopsyu00ae platform, which focuses on quantitative imaging biomarkers. For lung cancer, their technology aims to enhance screening and early detection by analyzing medical images. In liver cancer and liver disease, iBiopsyu00ae is designed to identify and characterize lesions, aiding in earlier diagnosis and treatment planning.
The iBiopsyu00ae platform plays a crucial role in oncology clinical trials by providing advanced medical image analysis and extracting imaging biomarkers. This data helps pharmaceutical companies assess treatment efficacy, stratify patient populations, and accelerate drug development. By identifying specific characteristics from images, iBiopsyu00ae supports precision medicine approaches, allowing for more targeted therapies based on individual patient profiles.
Median Technologies adheres to stringent regulatory standards for its medical image analysis and AI diagnostic products. They hold certifications such as ISO 13485, which is essential for medical device manufacturers, and their products are CE-marked, indicating compliance with European health, safety, and environmental protection standards. The company also pursues FDA clearance for its solutions to be used in the United States.
While specific pricing details are typically provided upon direct inquiry and depend on the scope of implementation, Median Technologies generally offers flexible models for its iBiopsyu00ae platform and services. These can include licensing agreements, per-study fees for clinical trials, or subscription-based models for diagnostic tools. Their support models encompass technical assistance, training, and ongoing maintenance to ensure seamless integration and operation within healthcare systems.
Median Technologies actively collaborates with a range of partners, including major pharmaceutical companies, leading cancer research institutions, and healthcare providers. These partnerships are crucial for validating their AI diagnostics, advancing imaging biomarker research, and integrating their solutions into clinical workflows. Such collaborations help accelerate the development and adoption of their technologies in oncology and other therapeutic areas.
Median Technologies demonstrates a strong commitment to long-term stability and growth, driven by continuous innovation in AI and imaging biomarkers. Their vision includes expanding the iBiopsyu00ae platform's capabilities to address a wider range of cancers and diseases, as well as increasing their global market presence. The company's strategic investments in R&D and key partnerships underscore its dedication to remaining a leader in AI-powered precision medicine.

Related Companies

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Google Workspace provides a comprehensive suite of secure online productivity and collaboration tools designed for various organizational sizes, including businesses, enterprises, and frontline workers. For physicians and healthcare professionals, Google Workspace offers a secure environment for communication, data storage, and document management, which is crucial for maintaining patient confidentiality and operational efficiency. The platform integrates […]

Pacmed is an Amsterdam-based clinical intelligence company that develops and implements AI solutions to improve hospital care, with a particular focus on the Intensive Care Unit (ICU). The company’s core product, Pacmed Critical, is an AI platform designed to optimize ICU capacity, enhance patient outcomes, and provide data-driven insights for medical professionals. This platform integrates […]

AiZtech Labs is a pioneering deep tech company that leverages AI to transform healthcare by providing accessible and rapid screening tools. Their mission is to enhance the quality of life for one billion people by blending world-class AI research with human-centered design. The company’s flagship platform, iSelfie BioSignals, utilizes a smartphone camera to detect digital […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.